Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract.

Soderquist CR, Patel N, Murty VV, Betman S, Aggarwal N, Young KH, Xerri L, Leeman-Neill R, Lewis SK, Green PH, Hsiao S, Mansukhani MM, Hsi ED, de Leval L, Alobeid B, Bhagat G.

Haematologica. 2019 Sep 26. pii: haematol.2019.230961. doi: 10.3324/haematol.2019.230961. [Epub ahead of print]

2.

Cytogenetic analysis of 130 renal oncocytomas identify three distinct and mutually exclusive diagnostic classes of chromosome aberrations.

Anderson CB, Lipsky M, Nandula SV, Freeman CE, Matthews T, Walsh CE, Li G, Szabolcs M, Mansukhani MM, McKiernan JM, Murty VV.

Genes Chromosomes Cancer. 2019 May 21. doi: 10.1002/gcc.22766. [Epub ahead of print]

PMID:
31112346
3.

Cytogenetic analysis of adult T-Cell leukemia/lymphoma: evaluation of a Caribbean cohort.

Sun Y, Murty VV, Leeman-Neill R, Soderquist C, Park D, Neill DB, Bhagat G, Alobeid B.

Leuk Lymphoma. 2019 Jun;60(6):1598-1600. doi: 10.1080/10428194.2018.1538506. Epub 2018 Nov 27. No abstract available.

PMID:
30481077
4.

Role of Fluorescent In Situ Hybridization, Cholangioscopic Biopsies, and EUS-FNA in the Evaluation of Biliary Strictures.

Brooks C, Gausman V, Kokoy-Mondragon C, Munot K, Amin SP, Desai A, Kipp C, Poneros J, Sethi A, Gress FG, Kahaleh M, Murty VV, Sharaiha R, Gonda TA.

Dig Dis Sci. 2018 Mar;63(3):636-644. doi: 10.1007/s10620-018-4906-x. Epub 2018 Jan 20.

PMID:
29353443
5.

PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition.

Mathur D, Stratikopoulos E, Ozturk S, Steinbach N, Pegno S, Schoenfeld S, Yong R, Murty VV, Asara JM, Cantley LC, Parsons R.

Cancer Discov. 2017 Apr;7(4):380-390. doi: 10.1158/2159-8290.CD-16-0612. Epub 2017 Mar 2.

6.

The genetic landscape of dural marginal zone lymphomas.

Ganapathi KA, Jobanputra V, Iwamoto F, Jain P, Chen J, Cascione L, Nahum O, Levy B, Xie Y, Khattar P, Hoehn D, Bertoni F, Murty VV, Pittaluga S, Jaffe ES, Alobeid B, Mansukhani MM, Bhagat G.

Oncotarget. 2016 Jul 12;7(28):43052-43061. doi: 10.18632/oncotarget.9678.

7.

Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.

Tannenbaum-Dvir S, Glade Bender JL, Church AJ, Janeway KA, Harris MH, Mansukhani MM, Nagy PL, Andrews SJ, Murty VV, Kadenhe-Chiweshe A, Connolly EP, Kung AL, Dela Cruz FS.

Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000471. doi: 10.1101/mcs.a000471.

8.

Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.

Narayan G, Xie D, Ishdorj G, Scotto L, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A, Arias-Pulido H, Murty VV.

Genes Chromosomes Cancer. 2016 Feb;55(2):177-89. doi: 10.1002/gcc.22325. Epub 2015 Nov 6.

PMID:
26542757
9.

PCDH10, a novel p53 transcriptional target in regulating cell migration.

Shi D, Murty VV, Gu W.

Cell Cycle. 2015;14(6):857-66. doi: 10.1080/15384101.2015.1004935.

10.

MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system.

Gill KZ, Iwamoto F, Allen A, Hoehn D, Murty VV, Alobeid B, Bhagat G.

PLoS One. 2014 Dec 5;9(12):e114398. doi: 10.1371/journal.pone.0114398. eCollection 2014.

11.

DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification.

Camacho CV, Todorova PK, Hardebeck MC, Tomimatsu N, Gil del Alcazar CR, Ilcheva M, Mukherjee B, McEllin B, Vemireddy V, Hatanpaa K, Story MD, Habib AA, Murty VV, Bachoo R, Burma S.

Oncogene. 2015 Feb 19;34(8):1064-72. doi: 10.1038/onc.2014.29. Epub 2014 Mar 17.

12.

Well-differentiated papillary mesothelioma with invasive foci.

Churg A, Allen T, Borczuk AC, Cagle PT, Galateau-Sallé F, Hwang H, Murer B, Murty VV, Ordonez N, Tazelaar HD, Wick M.

Am J Surg Pathol. 2014 Jul;38(7):990-8. doi: 10.1097/PAS.0000000000000200.

PMID:
24618613
13.

Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization.

Gowrishankar B, Cahill L, Arndt AE, Al-Ahmadie H, Lin O, Chadalavada K, Chaganti S, Nanjangud GJ, Murty VV, Chaganti RS, Reuter VE, Houldsworth J.

BJU Int. 2014 Dec;114(6):881-90. doi: 10.1111/bju.12643. Epub 2014 Jul 15.

14.

c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNA.

Islam MA, Thomas SD, Murty VV, Sedoris KJ, Miller DM.

J Biol Chem. 2014 Mar 21;289(12):8521-31. doi: 10.1074/jbc.M113.505073. Epub 2014 Jan 24.

15.

Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts.

Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R, Brum A, Park D, Galili N, Mukherjee S, Teruya-Feldstein J, Raza A, Rabadan R, Berman E, Kousteni S.

Nature. 2014 Feb 13;506(7487):240-4. doi: 10.1038/nature12883. Epub 2014 Jan 15.

16.

One in four individuals of African-American ancestry harbors a 5.5kb deletion at chromosome 11q13.1.

Zainabadi K, Jain AV, Donovan FX, Elashoff D, Rao NP, Murty VV, Chandrasekharappa SC, Srivatsan ES.

Genomics. 2014 Apr;103(4):276-87. doi: 10.1016/j.ygeno.2014.01.001. Epub 2014 Jan 10.

17.

Genetics of follicular lymphoma transformation.

Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB, Ouillette P, Trifonov V, Rossi D, Tabbò F, Ponzoni M, Chadburn A, Murty VV, Bhagat G, Gaidano G, Inghirami G, Malek SN, Rabadan R, Dalla-Favera R.

Cell Rep. 2014 Jan 16;6(1):130-40. doi: 10.1016/j.celrep.2013.12.027. Epub 2014 Jan 2.

18.

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.

Shah S, Schrader KA, Waanders E, Timms AE, Vijai J, Miething C, Wechsler J, Yang J, Hayes J, Klein RJ, Zhang J, Wei L, Wu G, Rusch M, Nagahawatte P, Ma J, Chen SC, Song G, Cheng J, Meyers P, Bhojwani D, Jhanwar S, Maslak P, Fleisher M, Littman J, Offit L, Rau-Murthy R, Fleischut MH, Corines M, Murali R, Gao X, Manschreck C, Kitzing T, Murty VV, Raimondi S, Kuiper RP, Simons A, Schiffman JD, Onel K, Plon SE, Wheeler D, Ritter D, Ziegler DS, Tucker K, Sutton R, Chenevix-Trench G, Li J, Huntsman DG, Hansford S, Senz J, Walsh T, Lee M, Hahn CN, Roberts K, King MC, Lo SM, Levine RL, Viale A, Socci ND, Nathanson KL, Scott HS, Daly M, Lipkin SM, Lowe SW, Downing JR, Altshuler D, Sandlund JT, Horwitz MS, Mullighan CG, Offit K.

Nat Genet. 2013 Oct;45(10):1226-1231. doi: 10.1038/ng.2754. Epub 2013 Sep 8.

19.

PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.

Narayan G, Xie D, Freddy AJ, Ishdorj G, Do C, Satwani P, Liyanage H, Clark L, Kisselev S, Nandula SV, Scotto L, Alobeid B, Savage D, Tycko B, O'Connor OA, Bhagat G, Murty VV.

Genes Chromosomes Cancer. 2013 Nov;52(11):1030-41. doi: 10.1002/gcc.22098. Epub 2013 Aug 9.

PMID:
23929756
20.

Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma.

Lee JC, Hoehn D, Schecter J, Murty VV, Mansukhani MM, Alobeid B, Bhagat G.

Hum Pathol. 2013 Jul;44(7):1328-40. doi: 10.1016/j.humpath.2012.10.022. Epub 2013 Jan 28.

PMID:
23363648
21.

A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells.

Debata PR, Castellanos MR, Fata JE, Baggett S, Rajupet S, Szerszen A, Begum S, Mata A, Murty VV, Opitz LM, Banerjee P.

Gynecol Oncol. 2013 Apr;129(1):145-53. doi: 10.1016/j.ygyno.2012.12.005. Epub 2012 Dec 9.

PMID:
23234806
22.

Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1).

Xing L, Salas M, Zhang H, Gittler J, Ludwig T, Lin CS, Murty VV, Silverman W, Arancio O, Tycko B.

Mamm Genome. 2013 Feb;24(1-2):30-43. doi: 10.1007/s00335-012-9436-9. Epub 2012 Oct 25.

23.

Real-time PCR-based analysis of BRAF V600E mutation in low and intermediate grade lymphomas confirms frequent occurrence in hairy cell leukaemia.

Ewalt M, Nandula S, Phillips A, Alobeid B, Murty VV, Mansukhani MM, Bhagat G.

Hematol Oncol. 2012 Dec;30(4):190-3. doi: 10.1002/hon.1023. Epub 2011 Dec 22.

PMID:
22246856
24.

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.

Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R.

Cancer Cell. 2011 Dec 13;20(6):728-40. doi: 10.1016/j.ccr.2011.11.006. Epub 2011 Dec 1.

25.

Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.

Gonda TA, Glick MP, Sethi A, Poneros JM, Palmas W, Iqbal S, Gonzalez S, Nandula SV, Emond JC, Brown RS, Murty VV, Stevens PD.

Gastrointest Endosc. 2012 Jan;75(1):74-9. doi: 10.1016/j.gie.2011.08.022. Epub 2011 Nov 17.

PMID:
22100297
26.

Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.

Narayan G, Freddy AJ, Xie D, Liyanage H, Clark L, Kisselev S, Un Kang J, Nandula SV, McGuinn C, Subramaniyam S, Alobeid B, Satwani P, Savage D, Bhagat G, Murty VV.

Genes Chromosomes Cancer. 2011 Dec;50(12):1043-53. doi: 10.1002/gcc.20922. Epub 2011 Aug 24.

PMID:
21960365
27.

Aberrant T-cell antigen expression in B lymphoblastic leukaemia.

Hussein S, Gill KZ, Sireci AN, Colovai AI, Small T, Emmons FN, Murty VV, Bhagat G, Alobeid B.

Br J Haematol. 2011 Nov;155(4):449-56. doi: 10.1111/j.1365-2141.2011.08870.x. Epub 2011 Sep 19.

PMID:
21923643
28.

Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, Rossi D, Chadburn A, Murty VV, Mullighan CG, Gaidano G, Rabadan R, Brindle PK, Dalla-Favera R.

Nature. 2011 Mar 10;471(7337):189-95. doi: 10.1038/nature09730.

29.

Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis.

Narayan G, Murty VV.

Future Oncol. 2010 Oct;6(10):1643-52. doi: 10.2217/fon.10.114. Review.

30.

Cytogenetic abnormalities in reactive lymphoid hyperplasia: byproducts of the germinal centre reaction or indicators of lymphoma?

Sevilla DW, Murty VV, Sun XL, Nandula SV, Mansukhani MM, Alobeid B, Bhagat G.

Hematol Oncol. 2011 Jun;29(2):81-90. doi: 10.1002/hon.958. Epub 2010 Aug 5.

PMID:
20687199
31.

Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas.

Sevilla DW, Weeden EM, Alexander S, Murty VV, Alobeid B, Bhagat G.

Virchows Arch. 2009 Oct;455(4):323-36. doi: 10.1007/s00428-009-0837-4. Epub 2009 Oct 6.

PMID:
19806362
32.

FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes?

Yang W, Stotler B, Sevilla DW, Emmons FN, Murty VV, Alobeid B, Bhagat G.

Leuk Res. 2010 Apr;34(4):420-5. doi: 10.1016/j.leukres.2009.09.013. Epub 2009 Oct 1.

PMID:
19800120
33.

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

Narayan G, Scotto L, Neelakantan V, Kottoor SH, Wong AH, Loke SL, Mansukhani M, Pothuri B, Wright JD, Kaufmann AM, Schneider A, Arias-Pulido H, Tao Q, Murty VV.

Genes Chromosomes Cancer. 2009 Nov;48(11):983-92. doi: 10.1002/gcc.20703.

34.

3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.

Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, Wu J, Nandula S, Dutta B, Xie Y, Chin YR, Kim DI, Ferris JS, Gruvberger-Saal SK, Laakso M, Wang X, Memeo L, Rojtman A, Matos T, Yu JS, Cordon-Cardo C, Isola J, Terry MB, Toker A, Mills GB, Zhao JJ, Murty VV, Hibshoosh H, Parsons R.

Cancer Res. 2009 Aug 1;69(15):6299-306. doi: 10.1158/0008-5472.CAN-09-0820. Epub 2009 Jul 14.

35.

KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?

Lambe JS, Oble DA, Nandula SV, Sevilla DW, Colovai AI, Mansukhani M, Chari A, Murty VV, Alobeid B, Bhagat G.

Hematol Oncol. 2009 Dec;27(4):203-10. doi: 10.1002/hon.892.

PMID:
19337983
36.

Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement.

Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G.

Leuk Lymphoma. 2009 May;50(5):831-3. doi: 10.1080/10428190902795527. No abstract available.

PMID:
19330656
37.

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.

Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M, Cerri M, Rossi D, Murty VV, Zucca E, Gaidano G, Dalla-Favera R, Pasqualucci L, Bhagat G, Bertoni F.

Blood. 2009 May 14;113(20):4918-21. doi: 10.1182/blood-2008-08-174110. Epub 2009 Mar 3.

38.

Irs2 inactivation suppresses tumor progression in Pten+/- mice.

Szabolcs M, Keniry M, Simpson L, Reid LJ, Koujak S, Schiff SC, Davidian G, Licata S, Gruvberger-Saal S, Murty VV, Nandula S, Efstratiadis A, Kushner JA, White MF, Parsons R.

Am J Pathol. 2009 Jan;174(1):276-86. doi: 10.2353/ajpath.2009.080086. Epub 2008 Dec 18.

39.

Diffuse large B-cell lymphoma with TEL/ETV6 translocation.

Sevilla DW, Nandula SV, Colovai AI, Alexander S, Murty VV, Alobeid B, Bhagat G.

Hum Pathol. 2009 Apr;40(4):588-93. doi: 10.1016/j.humpath.2008.08.012. Epub 2008 Nov 7.

PMID:
18992913
40.

The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations.

Keller CE, Nandula S, Fisher J, Subramaniyam S, Vakiani E, Savage DG, Murty VV, Alobeid B, Bhagat G.

Am J Clin Pathol. 2008 Aug;130(2):193-201. doi: 10.1309/ELPKF130Q0MCMWU8.

PMID:
18628087
41.

Successful aging in a 70-year-old man with down syndrome: a case study.

Krinsky-McHale SJ, Devenny DA, Gu H, Jenkins EC, Kittler P, Murty VV, Schupf N, Scotto L, Tycko B, Urv TK, Ye L, Zigman WB, Silverman W.

Intellect Dev Disabil. 2008 Jun;46(3):215-28. doi: 10.1352/2008.46:215-228.

PMID:
18578579
42.

Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation.

Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, Hod E, Li K, Murty VV, Schupf N, Vilain E, Morris M, Haghighi F, Tycko B.

Nat Genet. 2008 Jul;40(7):904-8. doi: 10.1038/ng.174. Epub 2008 Jun 22.

PMID:
18568024
43.

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha.

Scotto L, Narayan G, Nandula SV, Subramaniyam S, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Schneider A, Arias-Pulido H, Murty VV.

Mol Cancer. 2008 Jun 17;7:58. doi: 10.1186/1476-4598-7-58.

44.

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, Murty VV.

Genes Chromosomes Cancer. 2008 Sep;47(9):755-65. doi: 10.1002/gcc.20577.

PMID:
18506748
45.

Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology.

Vakiani E, Basso K, Klein U, Mansukhani MM, Narayan G, Smith PM, Murty VV, Dalla-Favera R, Pasqualucci L, Bhagat G.

Hematol Oncol. 2008 Dec;26(4):199-211. doi: 10.1002/hon.859.

PMID:
18457340
46.

Chronic myeloid leukemia and HIV-infection.

Schlaberg R, Fisher JG, Flamm MJ, Murty VV, Bhagat G, Alobeid B.

Leuk Lymphoma. 2008 Jun;49(6):1155-60. doi: 10.1080/10428190802074601.

PMID:
18452074
47.

Molecular cytogenetic applications in analysis of the cancer genome.

Rao PH, Nandula SV, Murty VV.

Methods Mol Biol. 2007;383:165-85. doi: 10.1007/978-1-59745-335-6_11.

PMID:
18217685
48.

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.

Saal LH, Gruvberger-Saal SK, Persson C, Lövgren K, Jumppanen M, Staaf J, Jönsson G, Pires MM, Maurer M, Holm K, Koujak S, Subramaniyam S, Vallon-Christersson J, Olsson H, Su T, Memeo L, Ludwig T, Ethier SP, Krogh M, Szabolcs M, Murty VV, Isola J, Hibshoosh H, Parsons R, Borg A.

Nat Genet. 2008 Jan;40(1):102-7. Epub 2007 Dec 9.

49.

Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.

Laufer M, Nandula SV, Modi AP, Wang S, Jasin M, Murty VV, Ludwig T, Baer R.

J Biol Chem. 2007 Nov 23;282(47):34325-33. Epub 2007 Sep 11.

50.

Faithful tissue-specific expression of the human chromosome 21-linked COL6A1 gene in BAC-transgenic mice.

Xing L, Salas M, Lin CS, Zigman W, Silverman W, Subramaniyam S, Murty VV, Tycko B.

Mamm Genome. 2007 Feb;18(2):113-22. Epub 2007 Feb 28.

PMID:
17334655

Supplemental Content

Loading ...
Support Center